BR112012004134A2 - "composto derivado dee anel heterocíclico fundido, pró-droga, medicamento, e , uso do composto ou sal ou uma pró-droga do mesmo" - Google Patents

"composto derivado dee anel heterocíclico fundido, pró-droga, medicamento, e , uso do composto ou sal ou uma pró-droga do mesmo"

Info

Publication number
BR112012004134A2
BR112012004134A2 BR112012004134A BR112012004134A BR112012004134A2 BR 112012004134 A2 BR112012004134 A2 BR 112012004134A2 BR 112012004134 A BR112012004134 A BR 112012004134A BR 112012004134 A BR112012004134 A BR 112012004134A BR 112012004134 A2 BR112012004134 A2 BR 112012004134A2
Authority
BR
Brazil
Prior art keywords
prodrug
compound
medicament
salt
heterocyclic ring
Prior art date
Application number
BR112012004134A
Other languages
English (en)
Inventor
Sasaki Satoshi
Tanaka Yuta
Original Assignee
Takeda Pharmaceuticals Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43627972&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112012004134(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Pharmaceuticals Co filed Critical Takeda Pharmaceuticals Co
Publication of BR112012004134A2 publication Critical patent/BR112012004134A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
BR112012004134A 2009-08-26 2010-08-25 "composto derivado dee anel heterocíclico fundido, pró-droga, medicamento, e , uso do composto ou sal ou uma pró-droga do mesmo" BR112012004134A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2009195770 2009-08-26
JP2010015644 2010-01-27
PCT/JP2010/064413 WO2011024872A1 (ja) 2009-08-26 2010-08-25 縮合複素環誘導体およびその用途

Publications (1)

Publication Number Publication Date
BR112012004134A2 true BR112012004134A2 (pt) 2017-06-20

Family

ID=43627972

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012004134A BR112012004134A2 (pt) 2009-08-26 2010-08-25 "composto derivado dee anel heterocíclico fundido, pró-droga, medicamento, e , uso do composto ou sal ou uma pró-droga do mesmo"

Country Status (24)

Country Link
US (1) US8907089B2 (pt)
EP (1) EP2471790B1 (pt)
JP (1) JP5599802B2 (pt)
KR (1) KR20120078703A (pt)
CN (1) CN102574851A (pt)
AU (1) AU2010287492A1 (pt)
BR (1) BR112012004134A2 (pt)
CA (1) CA2771833A1 (pt)
CL (1) CL2012000461A1 (pt)
CR (1) CR20120095A (pt)
DO (1) DOP2012000048A (pt)
EA (1) EA201270311A1 (pt)
EC (1) ECSP12011747A (pt)
GE (1) GEP20146075B (pt)
IL (1) IL218323A0 (pt)
IN (1) IN2012DN02069A (pt)
MA (1) MA33589B1 (pt)
MX (1) MX2012002419A (pt)
NZ (1) NZ598749A (pt)
PE (1) PE20121326A1 (pt)
SG (1) SG178504A1 (pt)
TN (1) TN2012000084A1 (pt)
WO (1) WO2011024872A1 (pt)
ZA (1) ZA201201795B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5659159B2 (ja) * 2009-08-26 2015-01-28 武田薬品工業株式会社 縮合複素環誘導体およびその用途
CA2903357A1 (en) * 2013-03-14 2014-09-18 Glaxosmithkline Intellectual Property (No.2) Limited Furanopyridines as bromodomain lnhibitors

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436965B1 (en) 2000-03-02 2002-08-20 Merck Frosst Canada & Co. PDE IV inhibiting amides, compositions and methods of treatment
AU2001277731A1 (en) 2000-08-09 2002-02-18 Welfide Corporation Fused bicyclic amide compounds and medicinal use thereof
US7482366B2 (en) 2001-12-21 2009-01-27 X-Ceptor Therapeutics, Inc. Modulators of LXR
ES2421511T3 (es) 2001-12-21 2013-09-03 X Ceptor Therapeutics Inc Moduladores de LXR
WO2004020599A2 (en) 2002-08-29 2004-03-11 Curis, Inc. Hedgehog antagonists, methods and uses related thereto
WO2005033288A2 (en) * 2003-09-29 2005-04-14 The Johns Hopkins University Hedgehog pathway antagonists
US20050203081A1 (en) 2004-02-25 2005-09-15 Jinbo Lee Inhibitors of protein tyrosine phosphatase 1B
GB0420722D0 (en) 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
WO2008057468A1 (en) * 2006-11-02 2008-05-15 Curis, Inc. Small organic molecule regulators of cell proliferation
US20080194637A1 (en) 2006-11-02 2008-08-14 Curis, Inc. Small organic molecule regulators of cell proliferation
MY148636A (en) 2007-06-29 2013-05-15 Pfizer Benzimidazole derivatives
RU2364597C1 (ru) 2007-12-14 2009-08-20 Андрей Александрович Иващенко ГЕТЕРОЦИКЛИЧЕСКИЕ ИНГИБИТОРЫ Hh-СИГНАЛЬНОГО КАСКАДА, ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ НА ИХ ОСНОВЕ И СПОСОБ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ, СВЯЗАННЫХ С АББЕРАНТНОЙ АКТИВНОСТЬЮ Hh СИГНАЛЬНОЙ СИСТЕМЫ
JP4685891B2 (ja) 2008-02-19 2011-05-18 株式会社ハネックス 分離装置
US8217176B2 (en) 2008-02-26 2012-07-10 Takeda Pharmaceutical Company Limited Fused heterocyclic derivative and use thereof
JP2010015644A (ja) 2008-07-04 2010-01-21 Fujitsu Ltd スピンドル機構、電磁変換特性評価機、および情報記憶装置
GB0900484D0 (en) 2009-01-13 2009-02-11 Angeletti P Ist Richerche Bio Therapeutic agent

Also Published As

Publication number Publication date
KR20120078703A (ko) 2012-07-10
MA33589B1 (fr) 2012-09-01
JP5599802B2 (ja) 2014-10-01
ECSP12011747A (es) 2012-05-30
CL2012000461A1 (es) 2012-10-05
JPWO2011024872A1 (ja) 2013-01-31
TN2012000084A1 (en) 2013-09-19
DOP2012000048A (es) 2012-05-15
WO2011024872A1 (ja) 2011-03-03
GEP20146075B (en) 2014-04-10
PE20121326A1 (es) 2012-10-11
ZA201201795B (en) 2013-05-29
SG178504A1 (en) 2012-04-27
EP2471790B1 (en) 2015-03-18
EP2471790A1 (en) 2012-07-04
EA201270311A1 (ru) 2012-09-28
US8907089B2 (en) 2014-12-09
IN2012DN02069A (pt) 2015-08-21
EP2471790A4 (en) 2013-07-31
NZ598749A (en) 2013-01-25
MX2012002419A (es) 2012-04-19
US20120220570A1 (en) 2012-08-30
IL218323A0 (en) 2012-04-30
CN102574851A (zh) 2012-07-11
CA2771833A1 (en) 2011-03-03
AU2010287492A1 (en) 2012-03-29
CR20120095A (es) 2012-06-26

Similar Documents

Publication Publication Date Title
BRPI0810646A2 (pt) " compostos farmacêuticos ".
NL300998I2 (nl) Lusutrombopag of farmaceutisch aanvaardbare zouten of solvaten daarvan
BRPI1011813A2 (pt) "inalador"
BRPI0914802A2 (pt) Composto, pró-droga, medicamento, uso do composto ou uma pró-droga de mesmo.
HK1137027A1 (en) Pyrrolo-nitrogenous heterocyclic derivatives and the pharmaceutical use thereof
HK1187606A1 (zh) 取代的 -稠合含氮雜環化合物及其用途
BRPI0810928A2 (pt) "composição farmacêutica"
BRPI0814267A2 (pt) Agentes citotóxicos compreendendo novos derivados de tomaicmicina e o seu uso terapêutico.
BRPI0818193A2 (pt) composto, sal farmacêuticamente aceitável de um composto, composição farmacêutica, e, uso de um composto
BRPI0720637A2 (pt) Composto ou um sal farmaceuticamente aceitável, uma forma estereoisomérica, tautomérica ou polimórfica do mesmo, métodos para o tratamento de um hospedeiro e de tratamento de infecção, composição farmacêutica, e, uso do composto
BR112012004335A2 (pt) composto, composição farmacêutica, e, uso do composto.
SMT201400076B (it) Formulazioni farmaceutiche contro l'uso improprio di medicinali
BRPI0808246A2 (pt) "fralda descartável".
IL223819A0 (en) 3-amino-5,6-dihydro-1h-pyrazin-2-one derivatives useful for the treatement of alzheimer's disease and other forms of dementia
BRPI1013762A2 (pt) "derivados isoxazol-piridazina"
DK2178589T3 (da) Pulverinhalator
BRPI1013988A2 (pt) composto, composição farmacêutica , e, uso de um composto ou um sal farmacologicamente aceitável do mesmo
DK2146991T3 (da) Triazolopyridin-carboxamid-derivater, fremstilling af samme samt terapeutisk anvendelse deraf
BRPI0810957A2 (pt) "emplasto medicamentoso compreendendo 5-metila-1-fenila-2-(1h) piridona".
IL223543A (en) Pharmaceutical preparation containing 1– (4– (4– (4,3-dichloro-2 – fluorophenylamino) –7 – methoxyquinazoline – 6 – Iloxy) piperidine – 1 – il) Prof. 2 – an – 1 – on or a common pharmaceutical salt His and an acidic addition
DE502008002604D1 (de) Lageberechnung von Körperteilen unter Berücksichtigung der anatomischen Symmetrie
BR112013003530A2 (pt) ''produto farmacêutico, kit, uso e preparações''
BRPI0813587A2 (pt) Composto, uso do mesmo, e, composição farmacêutica
EP2145889A4 (en) HETEROCYCLIC FUSED CORE DERIVATIVE, PHARMACEUTICAL COMPOSITION COMPRISING THE DERIVATIVE, AND USE OF THE COMPOSITION FOR MEDICAL PURPOSES
BRPI0806529A2 (pt) Composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, uso de um composto, e, método de tratamento de um distúrbio de agregação de plaqueta

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]